Ikonisys S.A. (ALIKO.PA)
- Business Wire
Ikonisys: Hospitex Expands in Ukraine through a Partnership with Diagen LLC to Fight Cancer
PARIS, May 21, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces that Hospitex has signed a new distribution partnership in Ukraine with Diagen LLC, a leading Ukrainian distributor and laboratory services provider. This collaboration aims at reinforcing the Company’s commitment to the global fight against cancer.
- Business Wire
Ikonisys: Hospitex to Obtain International Patent for the BLOCKfast Cyto-Inclusion Kit
PARIS, May 15, 2024--Regulatory News: Ikonisys SA (Euronext Growth Paris: ALIKO), a company specializing in the early and accurate detection of cancers through a unique, fully automated solution for medical analysis laboratories, today announces that Hospitex International has obtained the international patent for the BLOCKfast cytoinclusion kit.
- Business Wire
Ikonisys Announces the Postponement of the Publication of Its Annual Financial Report
PARIS, April 30, 2024--Regulatory News: Ikonisys SA (ISIN Code: FR00140048X2 / Ticker: ALIKO) (Paris:ALIKO), a company specializing in the early and accurate detection of cancer with a unique and fully-automated solution for medical diagnostic labs, announces that the publication of its 2023 annual financial report will be made by May, 27 and not on April, 30.
